プログラム可能な次世代の超分子自己組み立て材料は,薬物投与システムとして使用できます
Hongwei Fu1,2, Weihao Gao2,3, Yixuan Tang2,3
1School of Chemistry and Chemical Engineering, Nanjing University of Science and Technology, Nanjing, 210094, PR China.
Bioactive materials
|February 12, 2026
まとめ
次世代の超分子自己組み立て材料 (SAM) は,プログラム可能な多機能薬物投与システム (DDS) を提供しています. このレビューでは,それらの設計,応用,および疾患治療の強化のための将来の可能性について詳細に説明します.
科学分野:
- マテリアルサイエンス 材料科学
- ナノテクノロジー ナノテクノロジー
- バイオメディカルエンジニアリング
背景:
- 超分子自己組み立て (SA) は生物学的複雑性を駆動し,リポソームや脂質ナノ粒子 (LNP) のような生物模倣薬剤投与システム (DDS) にインスピレーションを与えます.
- 現在のナノ医薬品は,薬剤の安定性,標的の投与,生物学的バリアの浸透,細胞内放出などの課題に直面しています.
研究 の 目的:
- 先進的なDDSアプリケーションのための超分子自己組み立て材料 (SAM) の包括的な分析を提供する.
- 次世代のSAMの特徴と革新的な設計ガイドラインを定義し,プログラミング性を強調する.
主な方法:
- 超分子自己組み立てメカニズムとSAMの歴史的発展のレビュー.
- 高度プログラム可能,サイズ/形態学制御,および多機能SAMの設計戦略の分析.
- 病気の治療におけるSAMの最近の応用に関する議論.
主要な成果:
- 次世代のSAMは,高度なプログラム性が特徴で,サイズ,形態,機能の正確な制御を可能にします.
- 革新的な設計ガイドラインは,薬物投与のための高度なSAMの作成を容易にする.
- SAMは,様々な病気の治療において,著しい進歩を示しています.
結論:
- プログラム可能なSAMの合理的な設計は,現在のDDSの制限を克服するために不可欠です.
- 将来の戦略は,人間の健康を改善するためにSAMベースのDDSの臨床応用を強化することに焦点を当てています.
- SAMに関する継続的な研究は,薬物投与と病気の治療法に革命をもたらすことを約束しています.
関連する概念動画
01:18Transdermal Drug Delivery Systems
3
Transdermal drug delivery systems (TDDS) enable the controlled release of drugs across the skin into systemic circulation. They are particularly advantageous for drugs with short half-lives or narrow therapeutic indices, as they maintain consistent plasma concentrations and reduce the risk of subtherapeutic or toxic levels.TDDS are categorized into monolithic, reservoir, and mixed systems. Monolithic systems embed the drug in a polymer matrix, where diffusion governs release. Reservoir systems...
3
01:23Ophthalmic Drug Delivery Systems
1
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
1
01:21Intrauterine Drug Delivery Systems
1
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
1
01:27Drug Delivery Systems: Different Types
1
Conventional oral drug products, termed immediate-release (IR) formulations, are engineered to promptly release their active pharmaceutical ingredient (API) upon ingestion, typically in tablets or capsules. This rapid release often results in swift drug absorption and consequent pharmacodynamic effects, although the timing and intensity can vary depending on the drug's properties. Prodrugs within these formulations require metabolic conversion to activate their pharmacodynamic effects,...
1
01:26Oral Drug Delivery Systems: Continuous-Release Systems
1
Continuous-release drug delivery systems offer a strategic approach to maintaining therapeutic drug levels over extended periods following oral administration. By modulating the release rate of active pharmaceutical ingredients, these systems minimize fluctuations in plasma concentrations, which enhances clinical efficacy and reduces the need for frequent dosing. Such characteristics make them particularly advantageous in managing chronic diseases where patient adherence and stable drug...
1
01:11Oral Drug Delivery Systems: Delayed-Release Systems
2
Delayed-release drug delivery systems are specialized pharmaceutical formulations designed to postpone the release of active compounds until the drug reaches a specific region of the gastrointestinal (GI) tract, typically the intestine. These systems are essential for drugs that may cause gastric irritation, are unstable in acidic environments, or need to exert therapeutic effects locally in the intestinal or colonic regions.The core feature of delayed-release systems is the use of enteric...
2